 Home > Active Ingredient News > Blood System > Br J Cancer: Delayed diagnosis of lymphoma patients is related to potential comorbidities

Br J Cancer: Delayed diagnosis of lymphoma patients is related to potential comorbidities

 Last Update: 2021-08-27
 Source: Internet
 Author: User

Tags

pure source 3

cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Non-Hodgkin's lymphoma (NHL) is a heterogeneous disease, including more than 60 solid states with different histological patterns, accounting for about 80%-90% of all lymphomas

These subtypes are relatively common in adults and have an increased incidence in the elderly

Delays in diagnosis often correspond to lower cancer survival rates

The diagnostic researchers aimed to assess the association between comorbidities and delays in diagnosis in DLBCL or FL patients in the UK during the period 2005-2013

Analysis of variance of clinical diagnosis delay in patients with DLBCL

The study included 30,078 and 15,551 patients diagnosed with DLBCL or FL

Analysis of variance of clinical diagnosis delay in FL patients

All in all, the results of the study revealed that potential comorbidities are related to the delay in diagnosis of DLBCL or FL patients

The results of the study revealed that potential comorbidities are related to the delayed diagnosis of DLBCL or FL patients

Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.